Kissei Pharmaceutical Co., Ltd. (4547) Press Release
Announcement for the Opnion by European Authorities on TAVNEOS
Earlier from Kissei Pharmaceutical
- Notice Concerning Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers
- Notice Concerning Status of Acquisition of Treasury Shares
- Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment
- Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results